• +39 06 916391
  • Lun - Ven: 8:00 - 17:00
  

ITC-Farma-newsITC Farma focusses on human potentials and skills by adopting industrial strategies that, in a perspective of open innovation, can stimulate conscious productivity and creativity, as well as personal and collective growth. In many cases this approach is perfectly in line with the advantages offered by European laws thanks to the LIFE 2020 funding programme for research and development, awarded to research projects that make use of tax credits and all those enabling technologies that are included in the so-called Industry 4.0 policy. But that is not all. Advantageous industrial approaches such as these often also produce a much more important result in socio-economic terms: the creation of a particular synergy between the worlds of academic research and of business. This kind of multidisciplinary conjunction provides mutual benefits even in the short term, primarily by avoiding the so-called “brain drain”, due to the opportunities it offers young graduates to enter sectors that are strategic for the country as a whole.

“It is thanks to European investments, made possible for Italian companies that intend to actively aim towards concrete technological innovation, that we have always tried to develop a virtuous model which aims to further strengthen the results we have achieved in the national pharmaceutical field through solid scientific and intellectual knowledge, and with entrepreneurs who are mainlyinvolved in the contract manufacturing sector in Italy” explains Guglielmo Frontini, the plant director of ITC Farma.

“It is no coincidence that – continues Frontini – even in the least promising moments, opportunities can be transformed into choices that lead to genuine improvement, also thanks to favourable European/Italian legislation and institutions that are particularly active and sensitive to industrial issues. In ITC we have made some carefully considered decisions, in the conviction that new pathways must be entered upon and explored with innovative sensitivity, while thinking of the continual metamorphosis that we are witnessing every day.

Today, after a tangible renewal implemented in our productive systems of packaging and of research and development, involving both the pharmaceutical and the nutraceutical sectors, we can see the first positive signs to indicate that we have taken the right direction.

Being reliable and competent provides a definite added value if investments lead to research and innovation, thanks to the opportunities that Europe and Italy have made available to relaunch industry.

For this reason – Frontini concludes – it is essential to investigate all the possible scenarios, looking to the future with courage and with perseverance, and without putting any limits on exploration.”

The Italian pharmaceutical company, a national leader in the sector of contract manufacturing, has decided to invest a further 5 million Euros in its production cycle during 2020, with the acquisition of new pharmaceutical packaging machines.

itc-farmaThe latest addition to ITC Farma is a new generation blister packaging machine with an exceptionally high productive capacity. It can handle several different materials (such as Aluminium, PVC, PVC/PVDC and paper) and is equipped with a “continuous printing” system for the materials of the blister. The decision to acquire this machine was made to further improve the company’s “lean” production, minimizing waste and if possible even eliminating it completely. This innovative process uses a solvent-free ink to print identifying information on blank reels just before the blister is sealed, which reduces the risk of using the wrong printed materials. It is a technologically advanced procedure that is perfectly in line with ITC Farma's corporate policy, which is increasingly sensitive to environmental issues. “This is an inevitable step towards improving our production processes in the area of lean transformation” states Guglielmo Frontini, the plant director of ITC Farma “because today intelligent options must be conceived, elaborated and adopted, so as to offer stakeholders the maximum guarantee for the quality of the product, right up until the last step of the production cycle, that of packaging. Furthermore, eco-friendly choices should not just be made by accident, but they must be an integral part of the virtuous attitude that our company has maintained for a long time. In fact, we consider innovation and sustainability as two elements that must be closely related to each other, today more than ever before, in order to build and strengthen an environmentally ethical approach, as an essential characteristic of our company”.

The company based at Pomezia near Rome goes from strength to strength, instituting superior strategies and equipping itself with the latest generation of innovative and technological instruments

itcfarma-ciclo-produttivo

ROME - Preparation, experience, competence, passion and innovative technologies that ensure success on the international markets. These are the values that make ITC Farma a leading pharmaceutical company. Our production division is an undeniable expression of faultless value and genuine excellence, thanks to the skills and qualifications of a unique staff, coordinated by the manager Tina Joubert and by targeted decisions to acquire new technologies, which have positioned ITC Farma in a highly innovative segment within the field of contract manufacturing. The tablet press Prexima 300, which won Pharma Manufacturing's annual Pharma Innovation Awards in 2018, the ARIA 900 fluid bed technology and the Adapta 100, all of which are made by I.M.A. (Automatic Machinery Industry), have recently been acquired. This has further enhanced the automation of manufacturing processes in ITC Farma, opening up new development opportunities and new commercial scenarios that can satisfy the multiple requirements of the pharmaceutical and nutraceuticals market on every front. 
“Among our goals” – explains Guglielmo Frontini, the plant director of ITC Farma – “there is that of making our progress increasingly innovative and impeccable, thanks to the training and competence of the people who work with us and all with the technological advances that are fundamental in our sector. This inevitable progression makes us less vulnerable to the socio-economic changes that are currentlyunderway and offers greater reliability to our stakeholders, since security is further reinforced for the benefit of the whole community.”

Comparto Produzione ITC Farma Resp. Tina Joubert Vice Resp. Angelo Negri (in the video) Operatore specializz. Emanuele Giovannotti (in the video) Operatore specializz. Doriano Persi (in the video).

Guarda il video

 

Synergy between universities and business is necessary for the economic growth of Italy

itc-uniROME – An effective company is able to make intelligent choices that can create added value over time. For this reason ITC Farma has decided to focus on young people, a practice that is becoming increasingly widespread in the pharmaceutical industry in Italy. According to data supplied by the INPS (the Italian Institute of Social Security) from 2014 to 2017 the numbers of people under the age of 35 employed by pharmaceutical companies increased by 11%, compared to a more static situation in the other manufacturing industries. “Young people represent a genuine strategic resource for the future” states Guglielmo Frontini, the plant director of ITC Farma. “In our organization we have invested a lot in young people, by means of research and development agreements made with the Department of Chemistry and Pharmaceutical Technologies of the Sapienza University of Rome. Being able to accompany these young people in their development is fundamental, especially in today's society, in which the progress of science and technology is rapidly evolving. These synergistic relationships, which can transform knowledge into business thanks to a process of technology transfer, are accompanied by levels of enthusiasm that inevitably favour new ideas and introduce new stimuli for research and development.” Frontini concludes by pointing out that: “It goes without saying that it is absolutely necessary for research to have a continuous renewal of its lifeblood, so as to keep the spark alive and to kindle new enthusiasms. That's why we in ITC Farma wish to cultivate tomorrow's talent today, while communicating passion, enthusiasm and mutual trust.” Stefano Di Manno, the head of quality-control of ITC Farma, shares these opinions. “The route that we have embarked upon, together with the academic council of the Department of Chemistry and Pharmaceutical Technologies of the Sapienza University, as well as the Italian Medicines Agency AIFA and the national federation of private pharmacies Federfarma, involves reducing the present gap between industry and universities, by creating synergies and strategic agreements. This will allow the Department to always stay in close contact with the outside world, maintaining and improving the levels of excellence that it has achieved thanks to a policy of constant renewal.” It is no coincidence that the latest figures for the pharmaceutical sector in Italy indicate investments in R&D, hi-tech plants and machinery that amount to 2.8 billion Euros a year. The pharmaceutical sector has become the flagship of Italian industry, the leader in the European Union, with around 32 billion Euros of manufacturing value added, 80% of which are accounted for by exports. This is an outstanding result in a volatile and changeable sector that today employs 66,000 people, 90% of whom are high school or university graduates. Approximately 6,400 of these employees work in the field of research, 52% of whom are young women.

From the left: Annalisa Garofano (studying for a Master's degree at the Sapienza University), Laura Luciani (ITC Farma quality control), Ilaria Stamegna, (studying for a Master's degree at the Sapienza University), Ilaria Esposito (ITC Farma R&D laboratory), Francesca Antonucci (undergraduate at the Sapienza University), Enrico Renzullo (undergraduate at the Sapienza University), Simone Esposito (undergraduate at the Sapienza University).

WATCH THE VIDEO

A meeting at the Sapienza University between the representatives of Italian pharmaceutical industries, and of Chinese pharmaceutical associations and research.

itcfarma-apre-cinesiROME - ITC Farma has recently participated in an international meeting held at the Sapienza University of Rome, promoted by Professor Bruno Botta and Professor Silvio Massimo Lavagna of the Department of Chemistry and Pharmaceutical Technology of the university. Guglielmo Frontini, the general manager and plant director of ITC Farma, said it was a very positive meeting during which the delegation representing the major Chinese pharmaceutical companies expressed considerable interest in the company, based in Pomezia to the south of Rome. “The qualitative leap forward made by our pharmaceutical company – says Frontini – is certainly bringing positive results in terms of the reliability of steady manufacturing processes, by means of a rigorously monitored production chain. Thanks to the latest investments this fact has been noticed also by our Chinese colleagues, who see our industrial activity, despite its fairly limited dimensions, as an example to be imitated. We arevery proud of this result which gives us another good reason to move ahead with all the innovative processes that we have begun”.